{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:50:58Z","timestamp":1792090258969,"version":"4.4.0"},"reference-count":24,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,9,1]]},"DOI":"10.2967\/jnumed.126.273010","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:20:25Z","timestamp":1791472825000},"page":"jnumed.126.273010","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical Evaluation on the Radiohybrid Tandem [\n                    <sup>18<\/sup>\n                    F]La- and [\n                    <sup>225<\/sup>\n                    Ac]Ac-rhPSMA-10.1 for Targeted \u03b1-Therapy of Prostate Cancer"],"prefix":"10.2967","author":[{"given":"Baiqing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Weidle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Seyfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kossatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bruchertseifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena-Livia","family":"Chilug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"D\u2019Alessandria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wurzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2026101511101319000_jnumed.126.273010v2.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06340-y"},{"key":"2026101511101319000_jnumed.126.273010v2.2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(23)00638-1","article-title":"Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study","volume":"25","author":"Sathekge","year":"2024","journal-title":"Lancet Oncol."},{"key":"2026101511101319000_jnumed.126.273010v2.3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.eururo.2024.09.020","article-title":"A meta-analysis and meta-regression of the efficacy, toxicity, and quality of life outcomes following prostate-specific membrane antigen radioligand therapy utilising lutetium-177 and actinium-225 in metastatic prostate cancer","volume":"87","author":"Dai","year":"2025","journal-title":"Eur Urol."},{"key":"2026101511101319000_jnumed.126.273010v2.4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.nucmedbio.2021.04.003","article-title":"The salivary glands as a dose limiting organ of PSMA-targeted radionuclide therapy: a review of the lessons learnt so far","volume":"98-99","author":"Heynickx","year":"2021","journal-title":"Nucl Med Biol."},{"key":"2026101511101319000_jnumed.126.273010v2.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.11.013"},{"key":"2026101511101319000_jnumed.126.273010v2.6","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.7150\/thno.106574","article-title":"Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer\u2014a systematic review and meta-analysis","volume":"15","author":"Ninatti","year":"2025","journal-title":"Theranostics."},{"key":"2026101511101319000_jnumed.126.273010v2.7","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1007\/s00259-024-06681-2","article-title":"Image-based dosimetry for [225Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics","volume":"51","author":"Liubchenko","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026101511101319000_jnumed.126.273010v2.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269744"},{"key":"2026101511101319000_jnumed.126.273010v2.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234922"},{"key":"2026101511101319000_jnumed.126.273010v2.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263371"},{"key":"2026101511101319000_jnumed.126.273010v2.11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41181-024-00246-2","article-title":"Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies","volume":"9","author":"Wurzer","year":"2024","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026101511101319000_jnumed.126.273010v2.12","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1007\/s00259-025-07313-z","article-title":"Organ and tumour dosimetry of 177Lu-rhPSMA-10.1, a novel PSMA-targeted therapy: results from a phase I trial","volume":"52","author":"Nagarajah","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026101511101319000_jnumed.126.273010v2.13","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201709532"},{"key":"2026101511101319000_jnumed.126.273010v2.14","unstructured":"Multi-system assessment of NOD.Cg-Prkdcscid Il2rgtm1Wjl\/SzJ mice. MPD:Jaxpheno20. Mouse Phenome Database website. https:\/\/phenome.jax.org. Accessed September 2025."},{"key":"2026101511101319000_jnumed.126.273010v2.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0761-x"},{"key":"2026101511101319000_jnumed.126.273010v2.16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41181-021-00120-5","article-title":"Automated synthesis of [18F]Ga-rhPSMA-7\/-7.3: results, quality control and experience from more than 200 routine productions","volume":"6","author":"Wurzer","year":"2021","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026101511101319000_jnumed.126.273010v2.17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13550-022-00942-7","article-title":"Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer","volume":"13","author":"Kunert","year":"2023","journal-title":"EJNMMI Res."},{"key":"2026101511101319000_jnumed.126.273010v2.18","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice","volume":"49","author":"Ullman-Culler\u00e9","year":"1999","journal-title":"Lab Anim Sci."},{"key":"2026101511101319000_jnumed.126.273010v2.19","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.7150\/thno.38236","article-title":"Preclinical evaluation of an 111In\/225Ac theranostic targeting transformed MUC1 for triple negative breast cancer","volume":"10","author":"Kelly","year":"2020","journal-title":"Theranostics."},{"key":"2026101511101319000_jnumed.126.273010v2.20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41181-025-00354-7","article-title":"It\u2019s a match: use of the radionuclide theranostic pair 133La\/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies","volume":"10","author":"Trommer","year":"2025","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026101511101319000_jnumed.126.273010v2.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262459"},{"key":"2026101511101319000_jnumed.126.273010v2.22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41181-023-00208-0","article-title":"[225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in\u00a0vitro and tumour and normal tissue uptake in\u00a0vivo in NRG mice with HER2-positive human breast cancer xenografts","volume":"8","author":"Kondo","year":"2023","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026101511101319000_jnumed.126.273010v2.23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00259-021-05538-2","article-title":"[68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment","volume":"49","author":"Peters","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026101511101319000_jnumed.126.273010v2.24","doi-asserted-by":"crossref","first-page":"1600821","DOI":"10.3389\/fonc.2025.1600821","article-title":"A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET\/CT and Monte Carlo simulation","volume":"15","author":"Duong","year":"2025","journal-title":"Front Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.273010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:10:18Z","timestamp":1792087818000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.273010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":24,"alternative-id":["10.2967\/jnumed.126.273010"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.273010","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}